Related Experiment Videos
Primary cardiac lymphoma treated with orthotopic heart transplantation: a case report
D D Yuh1, S H Kubo, G S Francis
1Division of Cardiovascular and Thoracic Surgery, University of Minnesota Hospital and Clinics, Minneapolis 55455.
Insights
Primary cardiac lymphoma is rare and deadly. This case details the first orthotopic heart transplant for this condition, highlighting challenges with managing rejection, sepsis, and tumor recurrence during immunosuppression and chemotherapy.
Area of Science:
- Cardiovascular Surgery
- Oncology
- Transplantation Immunology
Background:
- Primary cardiac lymphoma is an exceptionally rare malignancy with a poor prognosis.
- Advanced myocardial involvement at diagnosis contributes to high mortality rates.
- Conventional treatments for primary cardiac lymphoma have limited efficacy.
Observation:
- This report details the first documented case of primary cardiac lymphoma treated with orthotopic heart transplantation.
- The patient experienced severe acute rejection, neutropenic sepsis, and tumor recurrence post-transplant.
- These complications arose during the critical period of combined immunosuppression and chemotherapy.
Findings:
- Orthotopic heart transplantation was performed for primary cardiac lymphoma.
- The patient faced significant post-transplant complications including rejection, sepsis, and tumor recurrence.
- Successful management of combined immunosuppression and chemotherapy proved challenging.
Implications:
- This case underscores the complex management of primary cardiac lymphoma patients undergoing heart transplantation.
- Integrating immunosuppressive therapy with chemotherapy requires careful monitoring and adjustment.
- Further research is needed to optimize treatment strategies and improve outcomes for this rare condition.
Abstract:
Primary lymphoma of the heart is an extremely rare tumor. It is associated with a high mortality rate because of the advanced stage of myocardial involvement at initial presentation. Conventional surgical and medical treatments have not met with much success. This article reports the first case of primary cardiac lymphoma treated with orthotopic heart transplantation. The patient had hemodynamically significant severe acute rejection, neutropenic sepsis, and tumor recurrence during the late postoperative period, illustrating the difficulties associated with concomitant immunosuppression and tumor chemotherapy. Unfortunately, the patient died after a period of remission. Our approach to the integration of immunosuppression with chemotherapy, posttransplantation follow-up, and complications is discussed.